BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 25625110)

  • 1. Brain tumors: Special characters for research and banking.
    Kheirollahi M; Dashti S; Khalaj Z; Nazemroaia F; Mahzouni P
    Adv Biomed Res; 2015; 4():4. PubMed ID: 25625110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.
    Lunsford LD; Flickinger JC; Larson D
    Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global incidence of brain and spinal tumors by geographic region and income level based on cancer registry data.
    Bell JS; Koffie RM; Rattani A; Dewan MC; Baticulon RE; Qureshi MM; Wahjoepramono EJ; Rosseau G; Park K; Nahed BV
    J Clin Neurosci; 2019 Aug; 66():121-127. PubMed ID: 31133367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The therapy of infantile malignant brain tumors: current status?
    Kalifa C; Grill J
    J Neurooncol; 2005 Dec; 75(3):279-85. PubMed ID: 16195802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rationale and Design of a Phase 1 Clinical Trial to Evaluate HSV G207 Alone or with a Single Radiation Dose in Children with Progressive or Recurrent Malignant Supratentorial Brain Tumors.
    Waters AM; Johnston JM; Reddy AT; Fiveash J; Madan-Swain A; Kachurak K; Bag AK; Gillespie GY; Markert JM; Friedman GK
    Hum Gene Ther Clin Dev; 2017 Mar; 28(1):7-16. PubMed ID: 28319448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Umbilical Cord Blood: Counselling, Collection, and Banking.
    Armson BA; Allan DS; Casper RF
    J Obstet Gynaecol Can; 2015 Sep; 37(9):832-844. PubMed ID: 26605456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human neuro-specimen banking 1961-1992. The National Neurological Research Specimen Bank (a donor program of pre- and post-mortem tissues and cerebrospinal fluid/blood; and a collection of cryopreserved human neurological specimens for neuroscientists).
    Tourtellotte WW; Rosario IP; Conrad A; Syndulko K
    J Neural Transm Suppl; 1993; 39():5-15. PubMed ID: 8360665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Organization of the Pediatric Tumor Cell Bank of the Society of Pediatric Oncology and Hematology (GPOH)].
    Anderer U; Nöhren H; Koch I; Harms D; Dietel M
    Klin Padiatr; 1998; 210(1):1-9. PubMed ID: 9522297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The genetic basis of intradural spinal tumors and its impact on clinical treatment.
    Karsy M; Guan J; Sivakumar W; Neil JA; Schmidt MH; Mahan MA
    Neurosurg Focus; 2015 Aug; 39(2):E3. PubMed ID: 26235020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular pathology of malignant gliomas.
    Louis DN
    Annu Rev Pathol; 2006; 1():97-117. PubMed ID: 18039109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative Clinical Imaging Methods for Monitoring Intratumoral Evolution.
    Kim JY; Gatenby RA
    Methods Mol Biol; 2017; 1513():61-81. PubMed ID: 27807831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MDR1 P-glycoprotein is expressed by endothelial cells of newly formed capillaries in human gliomas but is not expressed in the neovasculature of other primary tumors.
    Tóth K; Vaughan MM; Peress NS; Slocum HK; Rustum YM
    Am J Pathol; 1996 Sep; 149(3):853-8. PubMed ID: 8780389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Cure for Cancer: Not If but When.
    Black KL
    Oncologist; 1997; 2(5):IX-X. PubMed ID: 10388068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positron emission tomography imaging of brain tumors.
    Wong TZ; van der Westhuizen GJ; Coleman RE
    Neuroimaging Clin N Am; 2002 Nov; 12(4):615-26. PubMed ID: 12687915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene therapy for human malignant brain tumors.
    Rainov NG; Ren H
    Cancer J; 2003; 9(3):180-8. PubMed ID: 12952303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiation therapy for primary intracranial germ-cell tumors.
    Wolden SL; Wara WM; Larson DA; Prados MD; Edwards MS; Sneed PK
    Int J Radiat Oncol Biol Phys; 1995 Jul; 32(4):943-9. PubMed ID: 7607968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ASA404, a vascular disrupting agent, as an experimental treatment approach for brain tumors.
    Bähr O; Gross S; Harter PN; Kirches E; Mawrin C; Steinbach JP; Mittelbronn M
    Oncol Lett; 2017 Nov; 14(5):5443-5451. PubMed ID: 29098034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology of primary CNS tumors in Iran: a systematic review.
    Jazayeri SB; Rahimi-Movaghar V; Shokraneh F; Saadat S; Ramezani R
    Asian Pac J Cancer Prev; 2013; 14(6):3979-85. PubMed ID: 23886218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical, radiological, and pathological features of 26 intracranial and intraspinal malignant peripheral nerve sheath tumors.
    Ren X; Wang J; Hu M; Jiang H; Yang J; Jiang Z
    J Neurosurg; 2013 Sep; 119(3):695-708. PubMed ID: 23829815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraarterial delivery of genetic vectors for the treatment of malignant brain tumors.
    Cohen ZR; Duvdevani R; Nass D; Hadani M; Ram Z
    Isr Med Assoc J; 2001 Feb; 3(2):117-20. PubMed ID: 11344821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.